Koers Carmat Other OTC
Aandelen
Medische apparatuur, benodigdheden & distributie
Omzet 2023 | 2,8 mln. 3,03 mln. | Omzet 2024 * | 14,85 mln. 16,06 mln. | Marktkapitalisatie | 88,23 mln. 95,41 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -53 mln. -57,31 mln. | Nettowinst (verlies) 2024 * | -38 mln. -41,09 mln. | EV/omzet 2023 | 59,2 x |
Nettoschuld 2023 * | 49,63 mln. 53,67 mln. | Nettoschuld 2024 * | 61,25 mln. 66,24 mln. | EV/omzet 2024 * | 10,1 x |
K/w-verhouding 2023 |
-3,09
x | K/w-verhouding 2024 * |
-2,22
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 78,87% |
Recentste transcriptie over Carmat
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stéphane Piat
CEO | Chief Executive Officer | - | 01-09-16 |
Alain Carpentier
FOU | Founder | 91 | 25-06-08 |
Director of Finance/CFO | - | 12-12-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alexandre Conroy
CHM | Chairman | 61 | 22-12-22 |
Director/Board Member | 85 | 12-04-16 | |
Pierre Bastid
BRD | Director/Board Member | 69 | 05-04-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,24% | 128 mld. | |
-8,89% | 11,26 mld. | |
+3,31% | 9,28 mld. | |
+35,16% | 5,42 mld. | |
-23,90% | 4,8 mld. | |
+8,20% | 3,45 mld. | |
-10,69% | 2,8 mld. | |
-12,15% | 2,1 mld. | |
-11,96% | 1,98 mld. |